Glimepiride Tablets
Glimepiride 1 Tabletis a sulfonylurea hypoglycemic drug that can be used in combination with insulin. In 2001, glimepiride 2 tablet(Dibei), as the first hypoglycemic product of Beilu Pharma, was first listed in China and belongs to the second class of national new drugs.
Productname:GlimepirideTabletsSpecifications:glimepiride1mg×30tablets;glimepiride2mg×15tablets;glimepiride2mg×30tabletsCharacteristics:WhitetabletIndications:AsoneoftheoralantidiabeticdrugsproducedbyBeiluPharma,ourglimepiridetabletsareonlysuitablefortype2diabetesthatcannotfullycontrolbloodsugarthroughdietcontrol,exercisetherapyandweightloss.Glimepiridetabletsarenotsuitablefortype1diabetes(forexample,thetreatmentofdiabeticpatientswithahistoryofketoacidosis),diabeticketoacidosisorTreatmentofpre-diabeticcomaorcoma.UsageandDosage:PleaserefertothepackageinsertAdversereactions,Contraindications,Precautions:Pleaserefertothepackageinsert.Storage:Shade,seal,andkeepinadryplace.Packaging:Aluminumplasticpackaging,15pillsate,1plate/box;15pillsate,2plates/box.Shelflife:24monthsAdvantagesofGlimepirideTabletsDoubleeffectdirectlyhitthehypoglycemiccoreDoubleeffect:Glimepiridetabletscanpromoteinsulinsecretionandimproveinsulinresistance.Atthesametime,itcanimprovethetwomajorpathophysiologicalabnormalitiesofinsulinsecretionandinsulinresistanceinpatientswithtype2diabetes.Efficientlyreducepostprandialbloodglucose,fastingbloodglucoseandglycosylatedhaemoglobinGlimepiride 2 mg oral tabletmonotherapycancomprehensivelyreduceFPGPPGandHbA1cinnewlydiagnosedT2DMpatientsCombinationtherapy,suchascombinedmetformin,acarbose,etc.,hasamoresignificantoverallhypoglycemiceffectLesshypoglycemia,lessweightimpact,highsafetyShort-termtreatment,theriskofglimepiridehypoglycemiaisonly1/3ofthatofGlibenclamideLong-termtreatment,theriskofglimepiridehypoglycemiaisonly1/7ofthatofGlibenclamideGlimepiridehasasmallimpactontheweightofT2DMpatientsOnceadaytoimprovepatientcomplianceIfthepatient'scomplianceispoor,Glimepiridetabletsshouldbeselected,onceaday.
Beijing pharmaceuticalsisa professional contrast media manufacturer, we provideglimepiride 1mg tablets, glimepiride tab 1mg, glimepiride package insert, mri contrast mediumand etc. Want to know glimepiride 2mg tablets used foror side effects of glimepiride 1mg tablet? Please contact us.
Send product request
Other supplier products
| Gadobenate Dimeglumine Injection | What's New at Beilu Beilu Pharmaceutical has been awarded BeiluPharmaceutical has been awarded "Beijing Advanced Unit of Adverse Drug Reactions D... | |
| Ferric Ammonium Citrate Effervescent Granules | Ferric Ammonium Citrate Effervescent Granules was launched in 2004. It is an oral magnetic resonance contrast agent/media approved by NMPA in the m... | |
| Iopamidol Injection | IopamidolInjection is the second-generation non-ionic iodinated Contrast Media launched in the global market. In 2015, Beilu firstly launched and l... | |
| Contrast Media | For the purpose of medical imaging, a certain substance is introduced into the human body to change the image contrast of local tissues of the body... | |
| Gadopentetate Dimeglumine Injection/API | Since Gadopentetate Dimeglumine Injectionwas launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist, ... |
Same products
| Disposable Syringe Suppliers | Seller: 866413 | Zhejiang INI Medical Devices Co., Ltd. has specialized in sterile medical devic... | |
| Mold Components | Seller: Packson Mold Co.,Ltd | We provide custom made plastic parts-Sliders, inserts, lifters, blocks, ejector pins, and other m... | |
| Custom Metal Machining Parts | Seller: Packson Mold Co.,Ltd | Packson provides our customers a various CNC machining services to our customers, including milli... | |
| Clean Room Injection | Seller: Packson Mold Co.,Ltd | Packson - Medial Injection Moulding Cleanroom Expert Packson specializes in delivering top-notch ... | |
| Medical Plastic Injection Molding | Seller: Packson Mold Co.,Ltd | Packson - Medical Plastic Injection Molding Expert Packson sets itself apart from other medical i... |













